URGN compared with IMTX: revenue, margins and what each company keeps, and the suppliers and customers both name

URGNUroGen Pharma Ltd.

Mkt capRevenueRevenue

IMTXImmatics N.V.

Mkt capRevenueRevenue

Compare

URGNUroGen Pharma Ltd.

IMTXImmatics N.V.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

URGN

1 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±16.0%▲+16.31%×1.02

May 6 '26±16.0%▲+10.16%×0.64

Q1 FY26±20.4%▼−12.35%×0.60

Nov 6 '25±22.6%▲+21.91%×0.97

IMTX

No earnings history for IMTX.

= impliedURGN realized, solidIMTX realized, hatchedOne scale, both sides: full bar = 23%× = |realized| ÷ impliedSource: market data

URGNUroGen Pharma Ltd.

32.70▼−0.06%· post 34.42· delayed

Mkt cap$1.6BRevenue$72MQ2 FY26Revenue$110MFY25

IMTXImmatics N.V.

7.05▼−2.03%· post 7.05· delayed

After hoursNov 2 '26delayed

Mkt cap$965.3MRevenue—Revenue—

Compare

After hoursNov 2 '26delayed

URGNUroGen Pharma Ltd.

IMTXImmatics N.V.

32.70▼−0.06%post 34.42delayed

Price

7.05▼−2.03%post 7.05delayed

$1.6B

Mkt cap

$965.3M

Q2 FY26$72M

Revenue

—

FY25$110M

Revenue

—

URGN32.70▼−0.06%vsIMTX7.05▼−2.03%After hoursNov 2 '26delayed